Clip
Reversing APOE4 damage — what a hepatitis drug reveals about Alzheimer's and possible treatment | Axel Montagne, Ph.D.
“Dr. Montagne's animal research demonstrated that blocking cyclophilin A partially restored vascular function and cognition, suggesting that targeting the blood-brain barrier could be a promising avenue for Alzheimer's treatment.”